JPRN-UMIN000009638Completed未知
Study of the clinical effect of GLP-1 analogue for body weight, body fat, insulin secretion in patients with type 2 diabetes - Study of the clinical effect of GLP-1 analogue for body weight, body fat, insulin secretion in patients with type 2 diabetes
Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine0 sites130 target enrollmentStarted: December 26, 2012Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 130
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)severe ketosis, diabetic coma within 6 months 2)severe infection, before operation, severe trauma 3)pregnacy 4)Allergy for sitagliptin, nateglinide,liraglutide and exenatide 5)Patients judged by the investigator to be ineligible for some other reason
Investigators
Similar Trials
Active, not recruiting
Not Applicable
ELAD StudyEUCTR2013-000962-13-GBImperial College London
Active, not recruiting
Phase 1
GLIDE: Gastric band and Liraglutide Intervention in Diabetes EvolutioThis trial will investigate the effects of the study treatment arms (gastric band + placebogastric band + liraglutide) on diabetes resolution in obese patients.MedDRA version: 14.1 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-001538-41-GBniversity of Birmingham200
Active, not recruiting
Phase 1
GLIDE: Gastric band and Liraglutide Intervention in Diabetes EvolutioMedDRA version: 20.0 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disordersType 2 DiabetesEUCTR2015-005402-11-GBGuys and St Thomas NHS Foundation Trust58
Completed
Not Applicable
GLIDE: Gastric band and Liraglutide Intervention in Diabetes EvolutioDiabetes mellitusISRCTN10551314IHR Guy's & St Thomas' NHS Foundation Trust (GSTFT)/King’s College London (KCL) Biomedical Research Centre152
Recruiting
Not Applicable
Comparing effects of a long acting GLP-1 receptor agonist liraglutide with a short acting GLP-1 receptor agonist lixisenatide on diabetic cardiac autonomic neuropathy and glycemic variability evaluated by power spectral analysis of 24-hr heart rate and continuous glucose monitoring.Type 2 diabetesJPRN-UMIN000017144Department of Endocrinology and Metabolism, Dokkyo Medical University30